
Newsletter
FDA-cleared continuous AI sepsis monitor with a dedicated Medicare add-on payment.
Bayesian Health builds real-time clinical AI that flags patients at risk of sepsis earlier inside existing hospital workflows. Its sepsis flagging device received FDA Breakthrough designation and FDA clearance in April 2026, and was approved for a Medicare New Technology Add-on Payment under the CMS FY 2027 inpatient rule, effective October 1, 2026. Founder and CEO Suchi Saria, PhD, leads the company.
Leadership as of 14 November 2026.
Founder
Related companies